LP
LIMNW

LMR Partners’s Liminatus Pharma Warrants LIMNW Stock Holding History

LMR Partners’s Portfolio LIMNW Stock Details LIMNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.2K Hold
29,961
– – ﹤0.01% 1409
2025
Q4 		$1.05K Hold
29,961
– – ﹤0.01% 1481
2025
Q3 		$4.43K Hold
29,961
– – ﹤0.01% 1399
2025
Q2 		$7.19K Buy
+29,961
New +$5.89K ﹤0.01% 1295

Other funds holding LIMNW

AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.4% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 76.63% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.27% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

LMR Partners's LIMNW Position: Q1 2026 in Review

LMR Partners held its Liminatus Pharma Warrants (LIMNW) position steady in Q1 2026 at 29,961 shares worth $1.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1409.

LMR Partners first reported a position in LIMNW in Q2 2025 and has held it in 4 quarters since. The position peaked at $7.19K in Q2 2025. 21 funds tracked by Wall St. Rank hold LIMNW as of Q1 2026.

  • LMR Partners held 29,961 shares of Liminatus Pharma Warrants worth $1.2K as of Q1 2026.
  • LMR Partners left its Liminatus Pharma Warrants share count unchanged in Q1 2026.
  • Liminatus Pharma Warrants made up ﹤0.01% of LMR Partners's portfolio in Q1 2026, its #1409 holding.
  • LMR Partners first reported a position in Liminatus Pharma Warrants in Q2 2025 and has held it in 4 quarters since.
  • LMR Partners's Liminatus Pharma Warrants position peaked at $7.19K in Q2 2025.
  • 21 funds tracked by Wall St. Rank held Liminatus Pharma Warrants as of Q1 2026.

Based on LMR Partners's 13F filing for Q1 2026, filed 15 May 2026.